| MeSH term | MeSH ID | Detail |
|---|---|---|
| Brain Infarction | D020520 | 17 associated lipids |
| Hirsutism | D006628 | 3 associated lipids |
| Polycystic Ovary Syndrome | D011085 | 14 associated lipids |
| Hypocalcemia | D006996 | 12 associated lipids |
| Brain Ischemia | D002545 | 89 associated lipids |
| Endocrine System Diseases | D004700 | 4 associated lipids |
| Nerve Degeneration | D009410 | 53 associated lipids |
| Cystic Fibrosis | D003550 | 65 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Periodontitis | D010518 | 22 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Han G et al. | Effects of simvastatin on relapse and remodeling of periodontal tissues after tooth movement in rats. | 2010 | Am J Orthod Dentofacial Orthop | pmid:21055594 |
| Li F et al. | Effect of parathyroid hormone on experimental tooth movement in rats. | 2013 | Am J Orthod Dentofacial Orthop | pmid:24075660 |
| Enhos S et al. | OPG and RANKL levels around miniscrew implants during orthodontic tooth movement. | 2013 | Am J Orthod Dentofacial Orthop | pmid:23910201 |
| Baloul SS et al. | Mechanism of action and morphologic changes in the alveolar bone in response to selective alveolar decortication-facilitated tooth movement. | 2011 | Am J Orthod Dentofacial Orthop | pmid:21435543 |
| Kuang B et al. | Combined degenerative and regenerative remodeling responses of the mandibular condyle to experimentally induced disordered occlusion. | 2013 | Am J Orthod Dentofacial Orthop | pmid:23273362 |
| Flórez-Moreno GA et al. | Time-related changes in salivary levels of the osteotropic factors sRANKL and OPG through orthodontic tooth movement. | 2013 | Am J Orthod Dentofacial Orthop | pmid:23273364 |
| Galli C et al. | Effect of surface treatment on cell responses to grades 4 and 5 titanium for orthodontic mini-implants. | 2012 | Am J Orthod Dentofacial Orthop | pmid:22640672 |
| Kuczkowski J et al. | Expression of the receptor activator for nuclear factor-κB ligand and osteoprotegerin in chronic otitis media. | 2010 Nov-Dec | Am J Otolaryngol | pmid:20015790 |
| Røysland R et al. | Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial. | 2010 | Am. Heart J. | pmid:20691834 |
| Mogelvang R et al. | Comparison of osteoprotegerin to traditional atherosclerotic risk factors and high-sensitivity C-reactive protein for diagnosis of atherosclerosis. | 2012 | Am. J. Cardiol. | pmid:22100028 |
| Akat K et al. | Calcium metabolism in adults with severe aortic valve stenosis and preserved renal function. | 2010 | Am. J. Cardiol. | pmid:20211333 |
| Dahl JS et al. | Relation of osteoprotegerin in severe aortic valve stenosis to postoperative outcome and left ventricular function. | 2013 | Am. J. Cardiol. | pmid:23871267 |
| Abedin M et al. | Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study). | 2007 | Am. J. Cardiol. | pmid:17293196 |
| Schnabel RB et al. | Relation of multiple inflammatory biomarkers to incident atrial fibrillation. | 2009 | Am. J. Cardiol. | pmid:19576326 |
| Erkol A et al. | Relation of circulating osteoprotegerin levels on admission to microvascular obstruction after primary percutaneous coronary intervention. | 2011 | Am. J. Cardiol. | pmid:21247537 |
| Van Campenhout A et al. | Serum osteoprotegerin as a biomarker for vascular disease. | 2007 | Am. J. Cardiol. | pmid:17659953 |
| Shen C et al. | Relation between bone mineral density, bone loss and the risk of cardiovascular disease in a Chinese cohort. | 2012 | Am. J. Cardiol. | pmid:22762713 |
| Shea MK et al. | Vitamin K supplementation and progression of coronary artery calcium in older men and women. | 2009 | Am. J. Clin. Nutr. | pmid:19386744 |
| Shea MK et al. | Vitamin K, circulating cytokines, and bone mineral density in older men and women. | 2008 | Am. J. Clin. Nutr. | pmid:18689371 |
| Roux S et al. | RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone. | 2002 | Am. J. Clin. Pathol. | pmid:11863217 |
| Sato T et al. | Interleukin-11 as an osteoprotegerin-inducing factor in culture medium of blastic cells from a patient with acute megakaryocytic leukemia complicated with osteosclerosis. | 2004 | Am. J. Hematol. | pmid:15307108 |
| Elhasid R et al. | Familial severe congenital neutropenia associated with infantile osteoporosis: a new entity. | 2003 | Am. J. Hematol. | pmid:12508266 |
| Nuño-Arana I et al. | Distribution of three SNPs related to low bone mineral density in Amerindian groups and Mestizos from Mexico. | 2012 Jul-Aug | Am. J. Hum. Biol. | pmid:22434650 |
| Canto-Cetina T et al. | Polymorphism of LRP5, but not of TNFRSF11B, is associated with a decrease in bone mineral density in postmenopausal Maya-Mestizo women. | 2013 Nov-Dec | Am. J. Hum. Biol. | pmid:24130145 |
| Guerrini MM et al. | Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations. | 2008 | Am. J. Hum. Genet. | pmid:18606301 |
| Hocking LJ et al. | Genomewide search in familial Paget disease of bone shows evidence of genetic heterogeneity with candidate loci on chromosomes 2q36, 10p13, and 5q35. | 2001 | Am. J. Hum. Genet. | pmid:11555792 |
| Zagura M et al. | Association of osteoprotegerin with aortic stiffness in patients with symptomatic peripheral artery disease and in healthy subjects. | 2010 | Am. J. Hypertens. | pmid:20224558 |
| Noheria A et al. | Association of serum osteoprotegerin with left ventricular mass in African American adults with hypertension. | 2010 | Am. J. Hypertens. | pmid:20339356 |
| Ye Z et al. | Associations of candidate biomarkers of vascular disease with the ankle-brachial index and peripheral arterial disease. | 2013 | Am. J. Hypertens. | pmid:23467205 |
| Golledge J et al. | A single-nucleotide polymorphism in the gene encoding osteoprotegerin is associated with diastolic blood pressure in older men. | 2009 | Am. J. Hypertens. | pmid:19779468 |
| Nitta K et al. | The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis. | 2003 | Am. J. Kidney Dis. | pmid:12900812 |
| Coen G et al. | Serum leptin in dialysis renal osteodystrophy. | 2003 | Am. J. Kidney Dis. | pmid:14582047 |
| Nitta K et al. | Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis. | 2004 | Am. J. Kidney Dis. | pmid:15384019 |
| Fukagawa M et al. | Skeletal resistance to pth as a basic abnormality underlying uremic bone diseases. | 2001 | Am. J. Kidney Dis. | pmid:11576943 |
| Sato T et al. | Osteoprotegerin levels before and after renal transplantation. | 2001 | Am. J. Kidney Dis. | pmid:11576949 |
| Kazama JJ et al. | Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure. | 2002 | Am. J. Kidney Dis. | pmid:11877571 |
| Haas M et al. | Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients. | 2002 | Am. J. Kidney Dis. | pmid:11877577 |
| Gottesman GS et al. | Auricular ossification: A newly recognized feature of osteoprotegerin-deficiency juvenile Paget disease. | 2016 | Am. J. Med. Genet. A | pmid:26762549 |
| Kantaputra PN et al. | A newly recognized polyosteolysis/hyperostosis syndrome. | 2006 | Am. J. Med. Genet. A | pmid:17001672 |
| Tanaka S | Signaling axis in osteoclast biology and therapeutic targeting in the RANKL/RANK/OPG system. | 2007 | Am. J. Nephrol. | pmid:17652963 |
| Mazzaferro S et al. | Serum levels of calcification inhibition proteins and coronary artery calcium score: comparison between transplantation and dialysis. | 2007 | Am. J. Nephrol. | pmid:17259697 |
| Cozzolino M et al. | Vascular calcification and uremia: what do we know? | 2008 | Am. J. Nephrol. | pmid:18046081 |
| Nishiura R et al. | Elevated osteoprotegerin levels predict cardiovascular events in new hemodialysis patients. | 2009 | Am. J. Nephrol. | pmid:18802328 |
| Lewis JR et al. | Elevated osteoprotegerin predicts declining renal function in elderly women: a 10-year prospective cohort study. | 2014 | Am. J. Nephrol. | pmid:24457210 |
| Cianciolo G et al. | Importance of vascular calcification in kidney transplant recipients. | 2014 | Am. J. Nephrol. | pmid:24819032 |
| Bersinger NA et al. | PAPP-A and osteoprotegerin, together with interleukin-8 and RANTES, are elevated in the peritoneal fluid of women with endometriosis. | 2006 | Am. J. Obstet. Gynecol. | pmid:16635455 |
| Rhee EJ et al. | The effects of C161-->T polymorphisms in exon 6 of peroxisome proliferator-activated receptor-gamma gene on bone mineral metabolism and serum osteoprotegerin levels in healthy middle-aged women. | 2005 | Am. J. Obstet. Gynecol. | pmid:15846185 |
| Hong JS et al. | Maternal plasma osteoprotegerin concentration in normal pregnancy. | 2005 | Am. J. Obstet. Gynecol. | pmid:16157103 |
| Kawai T et al. | B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. | 2006 | Am. J. Pathol. | pmid:16936272 |
| Ohishi M et al. | Osteoprotegerin abrogated cortical porosity and bone marrow fibrosis in a mouse model of constitutive activation of the PTH/PTHrP receptor. | 2009 | Am. J. Pathol. | pmid:19389927 |
| Redlich K et al. | Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis. | 2004 | Am. J. Pathol. | pmid:14742260 |
| Biosse-Duplan M et al. | Histamine promotes osteoclastogenesis through the differential expression of histamine receptors on osteoclasts and osteoblasts. | 2009 | Am. J. Pathol. | pmid:19264900 |
| Yan J et al. | Bone marrow ablation demonstrates that excess endogenous parathyroid hormone plays distinct roles in trabecular and cortical bone. | 2012 | Am. J. Pathol. | pmid:22640808 |
| de Hooge AS et al. | Adenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-kappa B ligand. | 2002 | Am. J. Pathol. | pmid:12000725 |
| Lacey DL et al. | Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. | 2000 | Am. J. Pathol. | pmid:10934148 |
| Lawrie A et al. | Paigen diet-fed apolipoprotein E knockout mice develop severe pulmonary hypertension in an interleukin-1-dependent manner. | 2011 | Am. J. Pathol. | pmid:21835155 |
| Samee N et al. | Dlx5, a positive regulator of osteoblastogenesis, is essential for osteoblast-osteoclast coupling. | 2008 | Am. J. Pathol. | pmid:18669617 |
| Huang L et al. | Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation. | 2000 | Am. J. Pathol. | pmid:10702390 |
| Secchiero P et al. | An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction. | 2006 | Am. J. Pathol. | pmid:17148684 |
| Lawrie A et al. | Evidence of a role for osteoprotegerin in the pathogenesis of pulmonary arterial hypertension. | 2008 | Am. J. Pathol. | pmid:18156213 |
| Romas E et al. | Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis. | 2002 | Am. J. Pathol. | pmid:12368214 |
| Sato K et al. | RANKL synthesized by both stromal cells and cancer cells plays a crucial role in osteoclastic bone resorption induced by oral cancer. | 2013 | Am. J. Pathol. | pmid:23499553 |
| Wilkison M et al. | Type 1 interferons suppress accelerated osteoclastogenesis and prevent loss of bone mass during systemic inflammatory responses to Pneumocystis lung infection. | 2012 | Am. J. Pathol. | pmid:22626807 |
| Steagall WK et al. | Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene. | 2013 | Am. J. Pathol. | pmid:23867796 |
| Grimaud E et al. | Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis. | 2003 | Am. J. Pathol. | pmid:14578201 |
| Simionescu A et al. | Osteogenic responses in fibroblasts activated by elastin degradation products and transforming growth factor-beta1: role of myofibroblasts in vascular calcification. | 2007 | Am. J. Pathol. | pmid:17591959 |
| Mancini L et al. | Calcitonin and prednisolone display antagonistic actions on bone and have synergistic effects in experimental arthritis. | 2007 | Am. J. Pathol. | pmid:17322385 |
| Dela Cruz A et al. | Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate. | 2016 | Am. J. Physiol. Endocrinol. Metab. | pmid:27006198 |
| Cawley NX et al. | Obese carboxypeptidase E knockout mice exhibit multiple defects in peptide hormone processing contributing to low bone mineral density. | 2010 | Am. J. Physiol. Endocrinol. Metab. | pmid:20460579 |
| Wang L et al. | Targeted overexpression of G protein-coupled receptor kinase-2 in osteoblasts promotes bone loss. | 2005 | Am. J. Physiol. Endocrinol. Metab. | pmid:15585587 |
| Piemontese M et al. | Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice. | 2016 | Am. J. Physiol. Endocrinol. Metab. | pmid:27460899 |
| Vidal K et al. | Osteoprotegerin production by human intestinal epithelial cells: a potential regulator of mucosal immune responses. | 2004 | Am. J. Physiol. Gastrointest. Liver Physiol. | pmid:15521102 |
| Olesen P et al. | Calcification of human vascular smooth muscle cells: associations with osteoprotegerin expression and acceleration by high-dose insulin. | 2007 | Am. J. Physiol. Heart Circ. Physiol. | pmid:17056676 |
| Rashid G et al. | Parathyroid hormone decreases endothelial osteoprotegerin secretion: role of protein kinase A and C. | 2009 | Am. J. Physiol. Renal Physiol. | pmid:18945829 |
| Frick KK et al. | RANK ligand and TNF-alpha mediate acid-induced bone calcium efflux in vitro. | 2005 | Am. J. Physiol. Renal Physiol. | pmid:15972386 |
| Ragab AA et al. | Cytokines synergistically induce osteoclast differentiation: support by immortalized or normal calvarial cells. | 2002 | Am. J. Physiol., Cell Physiol. | pmid:12176725 |
| Villa I et al. | CGRP inhibits osteoprotegerin production in human osteoblast-like cells via cAMP/PKA-dependent pathway. | 2006 | Am. J. Physiol., Cell Physiol. | pmid:16611736 |
| Pacifici R | Osteoimmunology and its implications for transplantation. | 2013 | Am. J. Transplant. | pmid:23915249 |
| Bargnoux AS et al. | Evolution of coronary artery calcifications following kidney transplantation: relationship with osteoprotegerin levels. | 2009 | Am. J. Transplant. | pmid:19775319 |
| Byron CR et al. | In vitro expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in cultured equine articular cells. | 2010 | Am. J. Vet. Res. | pmid:20513175 |
| Ferrer Cañabate J et al. | [Osteoprotegrin and RANKL/RANK system: is it the future of bone metabolism?]. | 2002 | An Med Interna | pmid:12244784 |
| Bloch SL et al. | The viability of perilabyrinthine osteocytes: a quantitative study using bulk-stained undecalcified human temporal bones. | 2012 | Anat Rec (Hoboken) | pmid:22577084 |
| Sun Z and Tee BC | Molecular variations related to the regional differences in periosteal growth at the mandibular ramus. | 2011 | Anat Rec (Hoboken) | pmid:21157918 |
| Shiotani A et al. | Regulation of osteoclast differentiation and function by receptor activator of NFkB ligand and osteoprotegerin. | 2002 | Anat. Rec. | pmid:12221720 |
| Oshiro T et al. | Osteoclast induction in periodontal tissue during experimental movement of incisors in osteoprotegerin-deficient mice. | 2002 | Anat. Rec. | pmid:11920384 |
| McGonigle JS et al. | Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function. | 2009 | Angiogenesis | pmid:19105036 |
| Benslimane-Ahmim Z et al. | Mechanistic study of the proangiogenic effect of osteoprotegerin. | 2013 | Angiogenesis | pmid:23386104 |
| Mori K et al. | Effects of pravastatin on serum osteoprotegerin levels in patients with hypercholesterolemia and type 2 diabetes. | 2010 Feb-Mar | Angiology | pmid:19147525 |
| Shaker OG et al. | Possible role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as markers of plaque instability in coronary artery disease. | 2010 | Angiology | pmid:20498140 |
| Koshikawa M et al. | Elevated osteopontin levels in patients with peripheral arterial disease. | 2009 Feb-Mar | Angiology | pmid:18388057 |
| Toygar HU et al. | Osteoprotegerin in gingival crevicular fluid under long-term continuous orthodontic force application. | 2008 | Angle Orthod | pmid:18947279 |
| Tan L et al. | Osteoprotegerin and ligand of receptor activator of nuclear factor kappaB expression in ovariectomized rats during tooth movement. | 2009 | Angle Orthod | pmid:19216604 |
| Borsje MA et al. | Comparison of low-intensity pulsed ultrasound and pulsed electromagnetic field treatments on OPG and RANKL expression in human osteoblast-like cells. | 2010 | Angle Orthod | pmid:20050743 |
| Yu H et al. | Overexpression of osteoprotegerin promotes preosteoblast differentiation to mature osteoblasts. | 2011 | Angle Orthod | pmid:20936961 |
| Xu Y et al. | Regulation of the response of the adult rat condyle to intermaxillary asymmetric force by the RANKL-OPG system. | 2009 | Angle Orthod | pmid:19537860 |
| Rody WJ et al. | Differences in the gingival crevicular fluid composition between adults and adolescents undergoing orthodontic treatment. | 2014 | Angle Orthod | pmid:23687969 |
| Barbieri G et al. | Biochemical markers of bone metabolism in gingival crevicular fluid during early orthodontic tooth movement. | 2013 | Angle Orthod | pmid:22716279 |
| Jin Y et al. | Functional role of mechanosensitive ion channel Piezo1 in human periodontal ligament cells. | 2015 | Angle Orthod | pmid:24810489 |
| Telejko B et al. | The association of bone turnover markers with pro- and anti-inflammatory adipokines in patients with gestational diabetes. | 2015 | Ann Agric Environ Med | pmid:26094529 |
| Schwartz Z et al. | Osteoprotegerin (OPG) production by cells in the osteoblast lineage is regulated by pulsed electromagnetic fields in cultures grown on calcium phosphate substrates. | 2009 | Ann Biomed Eng | pmid:19139991 |